The Scientist

» biotech and disease/medicine

Most Recent

image: Psychedelic Neuroimaging

Psychedelic Neuroimaging

By | April 13, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Another Gene-Editing IPO

Another Gene-Editing IPO

By | April 12, 2016

Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.

0 Comments

image: Cancer Tissue Repository Launched

Cancer Tissue Repository Launched

By | April 11, 2016

The Dana-Farber Cancer Institute will store tissue samples from patients with leukemia and lymphoma from which scientists can make patient-derived mouse models.

0 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Shooting for the Moon

Shooting for the Moon

By | April 1, 2016

Defeating cancer is many times more difficult than planting a flag on our lunar satellite.

4 Comments

image: Inaccurate Cholesterol Tests from Theranos

Inaccurate Cholesterol Tests from Theranos

By | March 29, 2016

The company’s finger-prick tests yield cholesterol levels notably lower than results of traditional blood draw tests from two other large companies, according to a study.

0 Comments

image: Science Exchange Raises $25M

Science Exchange Raises $25M

By | March 24, 2016

With fresh funding, the experiment-services and independent-validation startup will expand its staff.

0 Comments

image: CDC Offers Advice to Limit Opioid Scripts

CDC Offers Advice to Limit Opioid Scripts

By | March 17, 2016

Aimed at primary care providers, the recommendations encourage non-narcotic alternatives or short-term opioid prescriptions and patient monitoring.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech